Infectious Disease/Immunology Stimulating Access to Research in Residency (ID/IMM StARR) Program at Washington University

华盛顿大学传染病/免疫学促进住院医师研究 (ID/IMM StARR) 项目

基本信息

  • 批准号:
    10592699
  • 负责人:
  • 金额:
    $ 41.8万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-06-16 至 2028-05-31
  • 项目状态:
    未结题

项目摘要

Abstract Due to their clinical and research training and expertise, physician-scientists are poised to provide new unique insights into disease, ultimately leading to advances in treatments. However, there has been a long-recognized shortage of physician-investigators. While combined MD-PhD programs have helped address this shortage, there are substantially more physicians without PhD degrees graduating from medical schools who form a substantial pool of potential investigators to overcome this shortage. Physician-scientists are especially needed to explore infectious diseases and immune-related diseases to derive new therapeutic advances. Here, the applicant and his team propose to meet this challenge by focusing on non-PhD physicians with a new R38 Stimulating Access to Research in Residency (StARR) Program in Infectious Disease and Immunology research (ID/IMM StARR) at Washington University School of Medicine (WUSM). The ID/IMM StARR Program is designed to provide protected time for mentored research, didactic training, and career development that will allow residents to fulfill board requirements and take advantage of the robust environment at WUSM for physician-scientist training and in ID/IMM research. The Specific Aims are to: Aim 1: Provide Dermatology, Medicine, Neurology, Pathology and Pediatric residents high quality, competency based, rigorous training in basic or clinical/translational ID/IMM research Aim 2: Provide 1-2 years of mentored research training, didactic training and other scientific enrichment activities, and Individual Development Plans for career development to ensure the success of residents in the StARR Program through close interaction with outstanding scientific mentors, career advisory committees and program directors Aim 3: Expand the number and diversity of well-trained residents ultimately performing research, and pursuing subspecialty fellowships to become independent research faculty in infectious disease and immunology Aim 4: Perform robust evaluation and tracking to demonstrate the impact of the StARR Program Thus, R38 residents will be well-prepared for an ultimate career as independent investigators in ID/IMM research.
抽象的 由于他们的临床和研究培训和专业知识,医生科学家准备提供新的独特 对疾病的见解,最终导致治疗的进展。但是,已经有一个长期认识的 缺乏医师评估者。虽然合并的MD-PHD计划帮助解决了这一短缺,但 从医学院毕业的医学院的医生大大增加了医学院 大量的潜在研究人员克服了这一短缺。特别需要医师科学家 探索传染病和免疫相关疾病,以获得新的治疗进展。在这里, 申请人及其团队建议通过专注于新R38的非PHD医生来应对这一挑战 刺激传染病和免疫学中居住研究(Starr)计划的访问 华盛顿大学医学院(WUSM)的研究(ID/IMM Starr)。 ID/IMM Starr程序 旨在为受保护的时间进行指导的研究,教学培训和职业发展,这将 允许居民满足董事会的要求,并利用WUSM的强大环境 医师科学家培训和ID/INM研究。具体目的是: 目标1:提供皮肤病学,医学,神经病学,病理学和儿科居民高质量,能力 基于基本或临床/翻译ID/IMM研究的严格培训 目标2:提供1 - 2年的指导研究培训,教学培训和其他科学丰富 活动和个人发展计划的职业发展计划,以确保居民的成功 在与杰出科学导师的紧密互动中,在Starr计划中,职业咨询 委员会主任 目标3:扩大训练有素的居民的数量和多样性最终进行研究,并追求 成为传染病和免疫学的独立研究学院的亚科奖学金 目标4:执行强大的评估和跟踪以证明Starr计划的影响 因此,R38居民将在ID/IMM的独立研究人员中做好充分的职业准备 研究。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Wayne M. Yokoyama其他文献

Structural basis of MHCI antigen presentation sabotage by cowpox CPXV203
  • DOI:
    10.1016/j.molimm.2012.02.034
  • 发表时间:
    2012-05-01
  • 期刊:
  • 影响因子:
  • 作者:
    William H. McCoy;Xiaoli Wang;Wayne M. Yokoyama;Ted H. Hansen;Daved Fremont
  • 通讯作者:
    Daved Fremont
Expression of a single inhibitory Ly49 receptor is sufficient to license NK cells for effector functions
单一抑制性 Ly49 受体的表达足以许可 NK 细胞发挥效应功能
  • DOI:
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Sytse J. Piersma;Shasha Li;Pamela Wong;Michael D. Bern;Jennifer Poursine‐Laurent;Liping Yang;D. L. Beckman;Bijal A. Parikh;Wayne M. Yokoyama
  • 通讯作者:
    Wayne M. Yokoyama
The mother-child union: the case of missing-self and protection of the fetus.
母子结合:自我缺失与胎儿保护案例

Wayne M. Yokoyama的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Wayne M. Yokoyama', 18)}}的其他基金

ORIGINS AND FUNCTIONS OF UTERINE NATURAL KILLER CELLS IN PREGNANCY
妊娠期子宫自然杀伤细胞的起源和功能
  • 批准号:
    10451584
  • 财政年份:
    2018
  • 资助金额:
    $ 41.8万
  • 项目类别:
ORIGINS AND FUNCTIONS OF UTERINE NATURAL KILLER CELLS IN PREGNANCY
妊娠期子宫自然杀伤细胞的起源和功能
  • 批准号:
    10216997
  • 财政年份:
    2018
  • 资助金额:
    $ 41.8万
  • 项目类别:
Translational Research Core
转化研究核心
  • 批准号:
    10472005
  • 财政年份:
    2018
  • 资助金额:
    $ 41.8万
  • 项目类别:
Translational Research Core
转化研究核心
  • 批准号:
    10251240
  • 财政年份:
    2018
  • 资助金额:
    $ 41.8万
  • 项目类别:
Translational Research Core
转化研究核心
  • 批准号:
    10019346
  • 财政年份:
    2018
  • 资助金额:
    $ 41.8万
  • 项目类别:
ORIGINS AND FUNCTIONS OF UTERINE NATURAL KILLER CELLS IN PREGNANCY
妊娠期子宫自然杀伤细胞的起源和功能
  • 批准号:
    9980287
  • 财政年份:
    2018
  • 资助金额:
    $ 41.8万
  • 项目类别:
ORIGINS AND FUNCTIONS OF UTERINE NATURAL KILLER CELLS IN PREGNANCY
妊娠期子宫自然杀伤细胞的起源和功能
  • 批准号:
    9762839
  • 财政年份:
    2018
  • 资助金额:
    $ 41.8万
  • 项目类别:
Natural Killer Cell Control of Murine Cytomegalovirus Infection
自然杀伤细胞控制鼠巨细胞病毒感染
  • 批准号:
    10444730
  • 财政年份:
    2017
  • 资助金额:
    $ 41.8万
  • 项目类别:
LIVER TISSUE-RESIDENT NATURAL KILLER CELLS
肝组织驻留自然杀伤细胞
  • 批准号:
    10116252
  • 财政年份:
    2017
  • 资助金额:
    $ 41.8万
  • 项目类别:
Natural Killer Cell Tolerance to Self
自然杀伤细胞对自身的耐受性
  • 批准号:
    9433623
  • 财政年份:
    2017
  • 资助金额:
    $ 41.8万
  • 项目类别:

相似海外基金

Unraveling how Lipophilic Modulators Alter pLGIC Function via Interactions with the M4 Transmembrane Helix
揭示亲脂性调节剂如何通过与 M4 跨膜螺旋相互作用改变 pLGIC 功能
  • 批准号:
    10785755
  • 财政年份:
    2023
  • 资助金额:
    $ 41.8万
  • 项目类别:
Cardiovascular Outcomes Research in Perioperative Medicine - COR-PM
围手术期医学心血管结局研究 - COR-PM
  • 批准号:
    10392118
  • 财政年份:
    2021
  • 资助金额:
    $ 41.8万
  • 项目类别:
Perioperative Cognitive Anesthesia Network Extension for Socially Vulnerable Older Adults
针对社会弱势老年人的围手术期认知麻醉网络扩展
  • 批准号:
    10633174
  • 财政年份:
    2021
  • 资助金额:
    $ 41.8万
  • 项目类别:
Perioperative Cognitive Anesthesia Network Extension for Socially Vulnerable Older Adults
针对社会弱势老年人的围手术期认知麻醉网络扩展
  • 批准号:
    10281822
  • 财政年份:
    2021
  • 资助金额:
    $ 41.8万
  • 项目类别:
Perioperative Cognitive Anesthesia Network Extension for Socially Vulnerable Older Adults
针对社会弱势老年人的围手术期认知麻醉网络扩展
  • 批准号:
    10475724
  • 财政年份:
    2021
  • 资助金额:
    $ 41.8万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了